» Articles » PMID: 35582296

Renal Manifestations of Hepatitis E Among Immunocompetent and Solid Organ Transplant Recipients

Abstract

Hepatitis E virus (HEV) infections are generally self-limited. Rare cases of hepatitis E induced fulminant liver failure requiring liver transplantation are reported in the literature. Even though HEV infection is generally encountered among developing countries, a recent uptrend is reported in developed countries. Consumption of unprocessed meat and zoonosis are considered to be the likely transmission modalities in developed countries. Renal involvement of HEV generally holds a benign and self-limited course. Although rare cases of cryoglobulinemia are reported in immunocompetent patients, glomerular manifestations of HEV infection are frequently encountered in immunocompromised and solid organ transplant recipients. The spectrum of renal manifestations of HEV infection include pre-renal failure, glomerular disorders, tubular and interstitial injury. Kidney biopsy is the gold standard diagnostic test that confirms the pattern of injury. Management predominantly includes conservative approach. Reduction of immunosuppressive medications and ribavirin (for 3-6 mo) is considered among patients with solid organ transplants. Here we review the clinical course, pathogenesis, renal manifestations, and management of HEV among immunocompetent and solid organ transplant recipients.

Citing Articles

Hepatitis E Virus Genotype 3 among Hemodialysis Patients in Mexico: First Identification of Chronic Infection.

Copado-Villagrana E, Duarte-Lopez I, Calderon-Flores A, Loera-Robles I, Viera-Segura O, Fierro N Pathogens. 2024; 13(7).

PMID: 39057805 PMC: 11280106. DOI: 10.3390/pathogens13070578.


Hepatitis E infection: A review.

Iqbal H, Mehmood B, Sohal A, Roytman M World J Virol. 2024; 12(5):262-271.

PMID: 38187497 PMC: 10768387. DOI: 10.5501/wjv.v12.i5.262.


Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients.

Wu E, Koch N, Bachmann F, Schulz M, Seelow E, Weber U Pathogens. 2023; 12(6).

PMID: 37375540 PMC: 10301935. DOI: 10.3390/pathogens12060850.


Age and Gender Trends in the Prevalence of Markers for Hepatitis E Virus Exposure in the Heterogeneous Bulgarian Population.

Golkocheva-Markova E, Ismailova C, Kevorkyan A, Raycheva R, Zhelyazkova S, Kotsev S Life (Basel). 2023; 13(6).

PMID: 37374127 PMC: 10301971. DOI: 10.3390/life13061345.


Immunoglobulin A nephropathy associated with acute hepatitis E infection: First case report.

Cheema S, Cheema M, Gilani S, Cheema S Clin Nephrol Case Stud. 2023; 11:95-98.

PMID: 37363299 PMC: 10286734. DOI: 10.5414/CNCS111100.

References
1.
Sayed I, Vercouter A, Abdelwahab S, Vercauteren K, Meuleman P . Is hepatitis E virus an emerging problem in industrialized countries?. Hepatology. 2015; 62(6):1883-92. DOI: 10.1002/hep.27990. View

2.
Kar P, Karna R . A Review of the Diagnosis and Management of Hepatitis E. Curr Treat Options Infect Dis. 2020; 12(3):310-320. PMC: 7366488. DOI: 10.1007/s40506-020-00235-4. View

3.
Hering T, Passos A, Perez R, Bilar J, Fragano D, Granato C . Past and current hepatitis E virus infection in renal transplant patients. J Med Virol. 2014; 86(6):948-53. DOI: 10.1002/jmv.23915. View

4.
Zhang L, Jiao S, Yang Z, Xu L, Liu L, Feng Q . Prevalence of hepatitis E virus infection among blood donors in mainland China: a meta-analysis. Transfusion. 2016; 57(2):248-257. DOI: 10.1111/trf.13937. View

5.
Betjes M, Bajema I . The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited. J Nephrol. 2006; 19(2):229-33. View